why choose us

First received: August 23, 2022

Clinical Trial: Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction

Study Status: Completed

Recruit Status: Completed

Condition: Treatment of Dry Eye Disease With Meibomian Gland Dysfunction

Study Type: Interventional


Official Title: A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction

Brief Summary: The study is being conducted to evaluate the efficacy and safety of SHR8058 eye drops for patients with dry eye disease.

Read more